Online Only Articles

Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia

Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Biostatistics Shared Resource Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Division of Oncology, Washington University School of Medicine
Vol. 105 No. 8 (2020): August, 2020 https://doi.org/10.3324/haematol.2019.236810